Michael Nemzek Email and Phone Number
Executive leader with consistent, verifiable success in achieving rapid revenue and profit growth objectives within startups, public turnaround and rapid-change environments in life science and high-technology markets. Expertise in fast transformative strategy development and implementation, with several successful exits and several billion dollars in value creation for shareholders.Areas of expertise include:• P&L Management • Strategic Planning • Product Lifecycle Management • Marketing Communication and Branding• Marketing Management• Digital Marketing Deployment• Global Commercial Management (Sales, Service, Field Applications and Support)• Corporate Turnaround• Global Launch of Products• Development of Key Opinion Leaders• Partnership Management• Talent Recruitment & Development • Business Development • Advanced Instrumentation, Liquid Handling, Automation, Reagents, Assay and Software Development• Life Sciences, Genomics, NGS, DNA Sequencing, Drug Discovery, Cell Biology, Molecular Biology, Immunology, Proteomics, Bioinformatics and Microbiome AnalysisI have held senior executive leadership positions in public corporations including Affymetrix, Symyx Technologies and EG&G achieving highly successful growth. I have served in senior executive roles in start-ups that have become successful public companies by merger at multiples above market norms. These include Velocity11, acquired by Agilent Technologies, where I was Vice President of Marketing; Cellomics, Inc., acquired by Fisher Scientific, where I was Chief Business Officer; Tropix, Inc., acquired by Perkin Elmer - Applied Biosystems Division, where I was Vice President of Sales and Marketing; and Genosys Biotechnologies, Inc., acquired by Sigma Aldrich Corp., where I was Vice President of Sales and Marketing.
-
Chief Commercial OfficerTelesis BioCalifornia, United States -
President, Ceo, And Board MemberTierra Biosciences Apr 2022 - Sep 2024San Francisco Bay AreaTierra Biosciences is a synthetic biology company that accelerates the pace of discovery, enabling the next generation of bioengineered products. The company’s Tierra Protein Platform couples high-throughput custom protein manufacturing with the simplicity of online ordering. By leveraging cell-free protein production and artificial intelligence, Tierra is transforming the way its customers discover, screen, and develop novel proteins leading to world-changing discoveries supporting human health, global food security, and planetary sustainability. -
Chief Commercial OfficerSynthego Corporation 2019 - 2022Redwood City, CaSynthego is the genome engineering innovation company. The company’s automated, full-stack genome engineering platform enables broader access to CRISPR gene editing technology to accelerate basic scientific discovery, uncover cures for diseases and develop novel synthetic biology applications. Synthego’s vision is to transform complex biology into more predictable information science. Headquartered in Silicon Valley, Synthego serves scientists from the largest global biotechnology companies and leading universities to unlock the potential of gene editing. -
Chief Commercial OfficerMedgenome 2017 - 2019San Francisco Bay Area And Bangalore, IndiaFirst commercial leader for next-generation sequencing based research and diagnostics company headquartered in the San Francisco Bay Area with the mission to improve global health by decoding genetic information contained in an individual's genome. Built sales and marketing team from ground up. Launched next-generation sequencing services business including immune repertoire sequencing, tumor microenvironment analysis, neo-antigen prediction/neo-epitope prioritization, and large-scale clinical databases. -
PresidentRarecyte, Inc. 2015 - 2016Seattle, WaRareCyte develops and manufactures a rare cell-based liquid biopsy platform for oncology analysis and prenatal testing solutions for pharmaceutical, biotech, and research diagnostics. Built a sales and marketing team from the ground up and launched a sophisticated instrumentation, consumables and software platform focused on cell biology and genomic analysis. Achieved significant revenue in the first year of product launch. Additional responsibility for equity fundraising. -
Vice President Global Strategic MarketingAffymetrix (Now Thermofisher) 2011 - 2015San Francisco Bay AreaAffymetrix was a genetic analysis and translational medicine products and services company serving life science research, pharmaceutical, biotech, and clinical diagnostics markets. Global responsibility to manage and develop array genotyping product strategies, pricing strategies, product portfolio planning, in-licensing, product positioning, and phase-gate driven life cycle management. Managed processes from market research, product launch and after sales support. Maintained KOL relationships, managed external B2B relationships, led speaking engagements at international meetings and key account business development. Led the transformation from a catalog products business to scalable, customer-driven custom products business. Drove more than threefold genotyping revenue growth concurrent with a dramatic increase in market capitalization and ultimate acquisition by ThermoFisher. -
CeoCloud Biosciences, Inc. (Now Part Of Lexacloud Inc.) 2010 - 2011San Francisco Bay AreaCloud Biosciences developed a powerful and easy to use web-based platform allowing researchers to manage and analyze qPCR data and to collaborate with local team members and the broader worldwide scientific community. Co-founded the company, responsible for capitalization of business, conceptualizing and developing a novel cloud-based software platform and forming partnerships. Outsourced coding work to India. Combined with LexaCloud Inc. -
Vice President Of MarketingVelocity11 (Now Agilent Technologies) 2005 - 2009San Francisco Bay AreaVelocity11 developed and manufactured laboratory automation systems, liquid handling instrumentation, consumables and integration software for life sciences, pharmaceutical, molecular diagnostics and ag-biotech markets supporting cell biology, molecular biology, and genomics applications. A key member of the senior executive team responsible for creating a progressive and durable global brand in the automation category. Provided global leadership for strategic marketing, marketing communications, product management service, applications, and systems operations groups. Responsible for corporate strategy, brand creation, product roadmap, and customer satisfaction. Led the transformation of the product mix from a large bespoke system provider to scalable modular workstations with a focus on liquid handling. Noteworthy revenue growth, far outpacing the industry followed by successful exit through acquisition by Agilent Technologies. -
Vice President And General ManagerSymyx Technologies (Now Part Of Unchained Labs) 2003 - 2005San Francisco Bay AreaSymyx Technologies was a publicly traded developer and manufacturer of advanced automated workflow systems and software for life sciences, pharmaceuticals and chemicals R&D markets. General management accountability for advanced technology products business. Duties included P&L management, with global leadership role encompassing sales, marketing, business development, product development, engineering, platform R&D, operations/manufacturing and customer support. Led the transformation of the business from large custom systems to innovative modular products. Results included threefold growth in revenue and several hundred million dollar increase in market capitalization.
-
Executive Vice PresidentAspira Biosystems 2002 - 2003San Francisco Bay AreaAspira developed novel synthetic polymer-based artificial antibodies. Key senior leadership team member responsible for strategy, business development, deal execution, technology evangelization, and fundraising. -
Chief Business OfficerCellomics, Inc. (Now Thermofisher) 1998 - 2001Pittsburgh, PaCellomics developed advanced image-based cell analysis systems, software, and reagents for life science and drug discovery in pharmaceutical, biotech, and academic markets. Founding global commercial leader with responsibility for creating a new product/technology category and hiring a large team from the ground up. Leadership accountability for hiring and managing the business organization, business strategy, business development, sales, marketing, product management, marketing & corporate communications, R&D collaboration management, service, field applications support and technical support operations. Successful creation of a new market category with impressive growth followed by an exit via acquisition by Fisher Scientific (now Thermo).
-
Vice President Of MarketingApplied Biosystems (Now Thermofisher) 1996 - 1998Greater Boston AreaGlobal marketing and business development responsibility for Applied Biosystems business unit in drug discovery and diagnostics markets. Conceived and launched a successful contract high-throughput compound screening lab service. Accountable for sales and marketing in a matrix organization. -
Vice President Of Sales And MarketingGenosys Biotechnologies (Now Milliporesigma) 1994 - 1996Houston, Texas AreaResponsible for commercial operations including sales, global product management, telemarketing and marketing communications teams for a leading manufacturer of synthetic DNA, peptides, antibodies and reagents to pharmaceutical, biotech and academic market segments. Successful growth into a global market leadership position and ultimate exit through acquisition by Sigma-Aldrich. -
Vice President Of Marketing And SalesTropix, Inc. (Now Thermofisher) 1991 - 1994Greater Boston AreaExecutive sales and marketing leader accountable for global commercial operations for a startup manufacturer of advanced chemiluminescent reagents for the diagnostics industry and biomedical research. Successfully grew business in multiple market segments followed by exit via acquisition by Perkin Elmer-Applied Biosystems.
-
Business Development ManagerEg&G (Now Perkinelmer) 1985 - 1991Greater Boston AreaSeveral positions of increasing responsibility in sales, sales management, business development, and corporate M&A for a variety of instrumentation, reagents, and software in industrial and life science market segments. #1 sales performer. Completed Master's degree in marketing management during this period. -
Technical Sales RepresentativeBioanalytical Systems 1984 - 1985Greater Chicago AreaField sales representative selling electrochemistry based instrumentation for chemical and neurochemical life science research for pharmaceutical, industrial, and academic accounts.
Michael Nemzek Education Details
-
Master’S Degree -
Master’S Degree -
Bachelor’S Degree
Frequently Asked Questions about Michael Nemzek
What company does Michael Nemzek work for?
Michael Nemzek works for Telesis Bio
What is Michael Nemzek's role at the current company?
Michael Nemzek's current role is Chief Commercial Officer.
What schools did Michael Nemzek attend?
Michael Nemzek attended North Carolina State University, University Of Maryland University College, University Of North Carolina At Charlotte.
Not the Michael Nemzek you were looking for?
-
1thinkingbeyond.com
-
1bellsouth.net
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial